AR110451A1 - Compuesto tricíclico que tiene sulfinilo y composición farmacéutica que lo comprende - Google Patents

Compuesto tricíclico que tiene sulfinilo y composición farmacéutica que lo comprende

Info

Publication number
AR110451A1
AR110451A1 ARP170103676A ARP170103676A AR110451A1 AR 110451 A1 AR110451 A1 AR 110451A1 AR P170103676 A ARP170103676 A AR P170103676A AR P170103676 A ARP170103676 A AR P170103676A AR 110451 A1 AR110451 A1 AR 110451A1
Authority
AR
Argentina
Prior art keywords
sulfinyl
pharmaceutical composition
tricyclic compound
compound
tricyclic
Prior art date
Application number
ARP170103676A
Other languages
English (en)
Inventor
Jun Sato
Katsuki Yokoo
Kenji Yamawaki
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of AR110451A1 publication Critical patent/AR110451A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Reivindicación 1: Un compuesto caracterizado porque es cualquiera de la fórmula seleccionada del grupo de fórmulas (1); su forma de éster o una de sus sales o hidratos farmacéuticamente aceptables.
ARP170103676A 2016-12-26 2017-12-22 Compuesto tricíclico que tiene sulfinilo y composición farmacéutica que lo comprende AR110451A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016251861 2016-12-26

Publications (1)

Publication Number Publication Date
AR110451A1 true AR110451A1 (es) 2019-03-27

Family

ID=62707667

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170103676A AR110451A1 (es) 2016-12-26 2017-12-22 Compuesto tricíclico que tiene sulfinilo y composición farmacéutica que lo comprende

Country Status (4)

Country Link
JP (1) JP2018104420A (es)
AR (1) AR110451A1 (es)
TW (1) TW201833119A (es)
WO (1) WO2018123920A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02289584A (ja) * 1989-02-17 1990-11-29 Takeda Chem Ind Ltd セファロスポリンγ―ラクトン化合物
US6599893B2 (en) * 2000-08-29 2003-07-29 Essential Therapeutics, Inc. Cephalosporin antibiotics and prodrugs thereof
TW200305422A (en) * 2002-03-18 2003-11-01 Shionogi & Co Broad spectrum cefem compounds
EP2703406A4 (en) * 2011-04-28 2015-08-05 Shionogi & Co NOVEL CEPHEM COMPOUND HAVING THE CATÉCHOL STRUCTURE OR A STRUCTURE CLOSE TO CATÉCHOL
JPWO2016175223A1 (ja) * 2015-04-28 2018-02-15 塩野義製薬株式会社 三環性化合物、およびそれらの使用
US20180186814A1 (en) * 2015-06-30 2018-07-05 Shionogi & Co., Ltd. Tricyclic compound having sulfinyl or sulfonyl

Also Published As

Publication number Publication date
TW201833119A (zh) 2018-09-16
WO2018123920A1 (ja) 2018-07-05
JP2018104420A (ja) 2018-07-05

Similar Documents

Publication Publication Date Title
CL2020001218A1 (es) Compuestos útiles para inhibir a cdk7.
CL2020000610A1 (es) Compuestos de bisamida que activan el sarcómero y sus usos.
CO2017012268A2 (es) Derivados de sulfamoilarilamida ciclados y su uso como medicamentos para el tratamiento de la hepatitis b
NI201700020A (es) Compuestos de aminopirimidinilo como inhibidores de jak
MA45244A (fr) Pyridines substituées utilisées en tant qu'inhibiteurs de dnmt1
EA201790649A1 (ru) Бензилзамещенные индазолы в качестве ингибиторов bub 1
EP3538078A4 (en) FORMULATIONS FOR EFFICIENT CANNABINOID DELIVERY
UY36121A (es) ?pirazolopiridinas y pirazolopirimidinas?.
CR20160538A (es) Combinación
EP3431075C0 (en) EDARAVONDAR FORM
CL2016002148A1 (es) Derivados de fenilen-1,5-diamina 2,4-disustituidos y aplicaciones de los mismos, y composiciones farmacéuticas y composiciones farmacéuticamente aceptables preparadas a partir de los mismos.
AR107864A1 (es) ÁCIDO 7a,11b-DIHIDROXI-6a-ETIL-5b-COLAN-24-OICO Y COMPOSICIONES FARMACÉUTICAS
UY36056A (es) “compuestos de heteroarilo o arilo bicíclicos fusionados “.
MA43120A (fr) Dérivé tricyclique contenant de l'azote présentant une activité inhibitrice de la réplication du vih
AR102981A1 (es) Inhibidores de la necrosis celular y métodos de preparación de los mismos
CR20170005A (es) Derivados de insoindolina
EP3449001A4 (en) INHIBITION OF MIR-22-MIRNA BY APT-110
CL2017000682A1 (es) Compuestos novedosos de imidazopiridazina y su uso.
MX2018013164A (es) Compuestos novedosos de imidazopiridina sustituida como inhibidores de indolamina-2,3-dioxigenasa y/o triptofano-2,3-dioxigenasa.
AR105967A1 (es) Sales de un inhibidor de pim quinasa
DOP2018000066A (es) Compuestos útiles para inhibir ror-gamma-t
EA201691792A1 (ru) Фармацевтические составы на основе вилдаглиптина
MA43764A (fr) Inhibiteur monovalent de l'interaction hutnfr1
MX380547B (es) Composición que comprende un inhibidor de fgfr1/kdr micronizado y el uso del mismo en el tratamiento de tumores neuroendocrinos.
CU20190002A7 (es) Combinación de un inhibidor de bcl-2 y un inhibidor de mcl1 para el tratamiento del cáncer y composiciones farmacéuticas que los comprenden

Legal Events

Date Code Title Description
FB Suspension of granting procedure